Skip to main content

Search form

You are here

Robin Elizabeth Bachelder, PhD

Associate Professor in Surgery
Associate Professor in Pathology
Division: 
Plastic, Maxillofacial, and Oral Surgery
Office: LSRC B217, Durham, NC 27710
Campus Mail: DUMC LSRC B217, 308 Research Drive, Durham, NC 27710

The long term goal of our laboratory is to identify novel therapeutic targets for triple-negative breast cancer (TNBC), which lacks estrogen receptor, progesterone receptor, and HER2. To reach this goal, we are studying: 1)  molecular determinants of TNBC therapy resistance, and 2) contributions of adipose stem cells to TNBC initiation/ progression.

Education and Training

  • Instructor in Medicine, Medicine, Harvard University , 1997 - 2005
  • Research Fellow, Pediatric Oncology, Harvard University , 1996 - 1997
  • Research Fellow, Medicine, Harvard University , 1995 - 1996
  • Ph.D., Harvard University , 1995

Publications

Bachelder, RE. "Cell Surface GRP78: A Targetable Marker of Cancer Stem-Like Cells." In Cell Surface GRP78, a New Paradigm in Signal Transduction Biology, 99-109. March 22, 2018.

Full Text

Nelson, ER, Li, S, Kennedy, M, Payne, S, Kilibarda, K, Groth, J, Bowie, M, Parilla-Castellar, E, de Ridder, G, Marcom, PK, Lyes, M, Peterson, BL, Cook, M, Pizzo, SV, McDonnell, DP, and Bachelder, RE. "Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface." Oncotarget 7, no. 51 (December 2016): 84030-84042.

Full Text

Li, S, Payne, S, Wang, F, Claus, P, Su, Z, Groth, J, Geradts, J, de Ridder, G, Alvarez, R, Marcom, PK, Pizzo, SV, and Bachelder, RE. "Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance." Breast cancer research : BCR 17 (July 4, 2015): 91-.

Full Text

Mo, L, Bachelder, RE, Kennedy, M, Chen, P-H, Chi, J-T, Berchuck, A, Cianciolo, G, and Pizzo, SV. "Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78." Molecular Cancer Therapeutics 14, no. 3 (March 2015): 747-756.

Full Text

Mo, L, Pospichalova, V, Huang, Z, Murphy, SK, Payne, S, Wang, F, Kennedy, M, Cianciolo, GJ, Bryja, V, Pizzo, SV, and Bachelder, RE. "Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells." Plos One 10, no. 7 (January 2015): e0131579-null.

Full Text

Li, S, Payne, S, Wang, F, Claus, P, Su, Z, Groth, J, Geradts, J, Ridder, GD, Alvarez, R, Marcom, PK, Pizzo, SV, and Bachelder, RE. "Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance." Breast Cancer Research (2015).

Full Text

Li, S, Kennedy, M, Payne, S, Kennedy, K, Seewaldt, VL, Pizzo, SV, and Bachelder, RE. "Model of tumor dormancy/recurrence after short-term chemotherapy." PloS one 9, no. 5 (January 2014): e98021-.

Full Text

Geradts, J, Herreros, AGD, Su, Z, Burchette, J, Broadwater, G, and Bachelder, RE. "Erratum:Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas (Human Pathology (2011) 42 (1125-1131))." Human Pathology 43, no. 10 (2012): 1787--.

Full Text

D'Amato, NC, Ostrander, JH, Bowie, ML, Sistrunk, C, Borowsky, A, Cardiff, RD, Bell, K, Young, LJT, Simin, K, Bachelder, RE, Delrow, J, Dawson, A, Yee, LD, Mrózek, K, Clay, TM, Osada, T, and Seewaldt, VL. "Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system." PLoS One 7, no. 9 (2012): e45684-.

Full Text

Geradts, J, de Herreros, AG, Su, Z, Burchette, J, Broadwater, G, and Bachelder, RE. "Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas." Hum Pathol 42, no. 8 (August 2011): 1125-1131.

Full Text

Pages